W
WAVEMAN · COMPANY
CDNA · Caredx, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

CDNA

CareDx, Inc.
HEALTHCARE SERVICES · SERVICES-MEDICAL LABORATORIES · CIK 0001217234
FORM 144 · 18☆ WATCH
INSIDER NET · 180D
-$12.4M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
134
13F, latest reported quarter
REVENUE GROWTH
+13.8%
XBRL, annual
NET MARGIN
-5.6%
CONVERSIONS · 180D
12
codes C/M, not in net · $2.1M priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$12.4M over 180 days
-$11.8M over 90 days
below 77% of Healthcare Services
CONGRESS
no member of Congress has reported trading it
FUNDS
134 funds added or opened last quarter
more than 51% of Healthcare Services
REVENUE
+13.8% year over year
more than 55% of Healthcare Services
MARGIN
-5.6% net margin
below 62% of Healthcare Services
BUYBACKS
$12.2M repurchased, FY to 2026-06-30
below 81% of Healthcare Services
SHORT
11.9% of shares outstanding short · 4.2 days to cover · settled 2026-07-31
more than 91% of Healthcare Services
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$12.4M across 7 people in 180 days.
134 funds added or opened positions in the latest 13F quarter, of 229 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +260.0%
+260.0%12M
-8%+87%+183%+278%2025-092025-102025-122026-032026-052026-072026-09 2026-07-16 · Hanna John Walter JR sold $2.7M2026-08-04 · Goldberg Michael sold $2.1M2026-07-16 · Hanna John Walter JR sold $1.8M2026-06-29 · Hanna John Walter JR sold $1.2M2026-07-16 · Valantine Hannah sold $1.0M2026-08-05 · Bickerstaff George sold $925.7K2026-08-04 · COURNOYER CHRISTINE sold $751.0K2026-06-11 · Hanna John Walter JR sold $528.4K2026-06-15 · Hanna John Walter JR sold $424.9K2026-01-22 · Hanna John Walter JR sold $408.0K2026-06-15 · Valantine Hannah sold $279.7K2026-04-16 · Hanna John Walter JR sold $217.2K2026-01-15 · Hanna John Walter JR sold $213.8K2025-12-04 · Novack Jeffrey Adam sold $134.2K2026-05-15 · TORRES ARTHUR A sold $129.0K2026-06-04 · Hanna John Walter JR sold $116.0K2026-08-05 · Novack Jeffrey Adam sold $101.0K2026-02-03 · Novack Jeffrey Adam sold $91.3K2026-05-14 · TORRES ARTHUR A sold $85.7K2026-05-05 · Novack Jeffrey Adam sold $55.6K2025-11-07 · Novack Jeffrey Adam sold $41.7K2026-08-05 · Novack Jeffrey Adam sold $23.4K2025-12-04 · Novack Jeffrey Adam sold $5.6K2026-01-21 · Hanna John Walter JR sold $4.2K2026-07-16 · Valantine Hannah sold $3.7K2026-06-26 · Hanna John Walter JR sold $2.9K2026-08-17 · PETER MAAG filed to sell $423.1K2026-08-14 · PETER MAAG filed to sell $317.1K2026-08-13 · PETER MAAG filed to sell $329.5K2026-08-12 · PETER MAAG filed to sell $328.2K2026-08-11 · PETER MAAG filed to sell $333.9K2026-08-10 · ARTHUR TORRES filed to sell $200.5K2026-08-10 · PETER MAAG filed to sell $328.9K2026-08-07 · PETER MAAG filed to sell $1.3M2026-08-05 · GEORGE W BICKERSTAFF filed to sell $925.7K2026-08-05 · JEFFREY NOVACK filed to sell $126.6K2026-08-05 · PETER MAAG filed to sell $2.2M2026-08-04 · CHRISTINE COURNOYER filed to sell $1.5M2026-08-04 · Christine M. Cournoyer filed to sell $753.4K2026-08-04 · PETER MAAG filed to sell $3.6M2026-08-04 · MICHAEL D. GOLDBERG FAM TRUST filed to sell $2.1M2026-07-16 · HANNAH VALANTINE filed to sell $856.2K2026-07-16 · JOHN WALTER HANNA filed to sell $3.5M2026-06-29 · JOHN HANNA filed to sell $1.1M
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $12.4M sold by insiders over 180 days, 134 funds added last quarter, $20.2M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, CareDx, Inc. insiders sold a net $12.4M of stock across 130 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Novack Jeffrey Adam
Secretary and General Counsel
SELL
2026-08-05
2,188.0
$101.0K
Novack Jeffrey Adam
Secretary and General Counsel
SELL
2026-08-05
500.0
$23.4K
Bickerstaff George
Director
SELL
2026-08-05
20,000.0
$925.7K
Goldberg Michael
Director
SELL
2026-08-04
44,700.0
$2.1M
COURNOYER CHRISTINE
Director
SELL
2026-08-04
16,000.0
$751.0K
130 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 125 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BlackRock, Inc.
4,814,709.0 sh
$137.2M
STATE STREET CORP
2,468,858.0 sh
$70.4M
VANGUARD CAPITAL MANAGEMENT LLC
2,197,475.0 sh
$62.6M
DEERFIELD MANAGEMENT COMPANY, L.P.
1,997,618.0 sh
$56.9M
ARK Investment Management LLC
1,953,531.0 sh
$55.7M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
PETER MAAG
FILED 2026-08-17
$423.1K
PETER MAAG
FILED 2026-08-14
$317.1K
PETER MAAG
FILED 2026-08-13
$329.5K
PETER MAAG
FILED 2026-08-12
$328.2K
PETER MAAG
FILED 2026-08-11
$333.9K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
ARK Genomic Revolution ETF
$41.8M POSITION · AS OF 2026-04-30
3.4%
Invesco Biotechnology & Genome ETF
$7.6M POSITION · AS OF 2026-04-30
3.1%
BARON DISCOVERY FUND
$41.6M POSITION · AS OF 2026-03-31
2.5%
WPG Partners Select Small Cap Value Fund
$4.3M POSITION · AS OF 2026-02-28
2.1%
ROBO Global Healthcare Technology and Innovation ETF
$983.2K POSITION · AS OF 2026-04-30
1.8%
Meridian Small Cap Growth Fund
$3.2M POSITION · AS OF 2026-03-31
1.4%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Clinical pipeline
ClinicalTrials.gov · 11 registered trials, 6 still enrolling or running — a status change here is dated weeks before the press release
11
Not applicable
6 ACTIVE
What changed recently
Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT)
2026-09-04 · Completion moved 2026-05-31 → 2026-10-15
—
TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$379.8M$333.8M$280.3M$321.8M
OPERATING INCOME$-30.8M$40.8M$-203.4M$-77.2M
NET INCOME$-21.4M$52.5M$-190.3M$-76.6M
EPS (DILUTED)-0.400.93-3.54-1.44
OPERATING CASH FLOW$42.0M$38.0M$-18.4M$-25.2M
CASH$65.4M$114.7M$82.2M$89.9M
BUYBACKS$87.8M$522.0K$27.5M$642.0K
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →